Prucalopride Versus Placebo in Gastroparesis
Prucalopride Versus Placebo in Functional Dyspepsia With Delayed Gastric Emptying
Sponsor: Universitaire Ziekenhuizen KU Leuven
Terminated
Prematurely stopped due to slow recruitment and expiry of study drug.
Other terminated trials from Universitaire Ziekenhuizen KU Leuven
- Ulcerative Colitis · Phase PHASE2/PHASE3 · Oct 2025
- Tibial Plateau Fracture · Dec 2024
- Hepcidin · Dec 2023
- Ovarian Cancer · Phase PHASE2 · Oct 2023
- Compress Compliant Pre-Stress System · Phase NA · Aug 2023
See all terminations from Universitaire Ziekenhuizen KU Leuven
Other Gastroparesis trials with similar outcome
This PHASE4 trial investigates Gastroparesis and is currently terminated or withdrawn. Universitaire Ziekenhuizen KU Leuven leads this study, which shows 8 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Aug 2024 — Sep 2024 [monthly]
Terminated PHASE4
Status: Unknown → Terminated
-
Jul 2024 — Aug 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Nov 2022 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Jan 2021 — Nov 2022 [monthly]
Unknown Status PHASE4
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE4
-
Aug 2017 — Jun 2018 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jan 2017 — Aug 2017 [monthly]
Recruiting PHASE4
First recorded
Nov 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Universitaire Ziekenhuizen KU Leuven
For direct contact, visit the study record on ClinicalTrials.gov .